NCT06357520View on ClinicalTrials.gov

A Study to Investigate the Pharmacokinetics of Baxdrostat When Given Alone and in Combination With Itraconazole in Healthy Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

14

Participants

Timeline

Start Date

April 16, 2024

Primary Completion Date

June 17, 2024

Study Completion Date

June 17, 2024

Conditions

Healthy Participants

Interventions

DRUG

Baxdrostat

Baxdrostat tablet will be administered orally.

DRUG

Itraconazole

Itraconazole capsule will be administered orally.

Trial Locations (1)

21225

Research Site, Brooklyn

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY